January 9, 2018 / 6:00 PM / Updated 11 minutes ago BRIEF-Nektar Therapeutics Says As Of Dec 31, 2017, Had Cash And Investments Of $353.2 Mln Reuters Staff 1 Min Read 
Jan 9 (Reuters) - Nektar Therapeutics: 
* NEKTAR THERAPEUTICS SAYS BASED ON PRELIMINARY ESTIMATES, AS OF DEC 31, 2017, COMPANY HAD CASH AND INVESTMENTS OF $353.2 MILLION - SEC FILING Source text: [ bit.ly/2AJ8qCb ] Further company coverage: